# TELA Bio, Inc.: Form 8-K, filed May 12, 2026

- Company: [TELA Bio, Inc.](/companies/tela.md) (CIK 1561921)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 20:11 ET
- Period: 2026-05-12
- Accession: 0001104659-26-059393
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1561921/000110465926059393/tm2614218d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1561921/000110465926059393/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1561921/000110465926059393/tm2614218d1_8k.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-059393. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.